Horse owners commonly add nutraceuticals to their horses’ diets to treat or prevent joint disease, but most products have no research data supporting their effectiveness.
Move over, Bute. In a new independent study, researchers at Colorado State University’s Gail Holmes Equine Orthopaedic Research Center concluded that diclofenac liposomal cream (1% diclofenac sodium, trade name Surpass) is safer and more
To evaluate the effect of PSGAG and HA on clinical signs and various other measures of osteoarthritis, researchers utilized 24 horses with a similar degree of osteoarthritis in one carpal joint.
No Joint, No Horse. Should this be the new motto for 21st century horses? Joint injury, joint disease secondary to trauma or injury, and osteoarthritis (OA) are major
Move over glucosamine and chondroitin sulfate, there might be a new supplement in town. In a clinical trial involving 74 trotting horses, LitoVet, a rose hip powder manufactured specifically for animals by HybenVital in Denmark, had an
In a recently completed 429-horse trial, researchers reinforced the effectiveness and safety profile of Equioxx (firocoxib), the first equine oral, nonsteroidal anti-inflammatory drug (NSAID) to be approved in more than 20 years.
“This
Questions and concerns abound surrounding the use of oral joint health supplements for horses with osteoarthritis, and so researchers continue their quest to determine if and how glucosamine works to decrease pain and inflammation caused by
Skeptics continue to doubt the effects of glucosamine and other oral joint health supplements, but mounting research seems to be proving, one step at a time, that there is more to these products than meets the eye.
Canadian researchers, led
The potential impact of intra-articular medications on the health of cartilage in joints has been debated for decades. Adding fuel to the fire is the recent finding that two common joint medications not only support cartilage cells, they also
Treatments for osteoarthritis in horses, including the doxycycline antibiotic and the nutraceutical Myristol, were discussed at the 2007 AAEP Convention. Also discussed were the clinical efficacy and joint health parameters of Surpass (topical liposomal diclofenac cream) compared to those of the commonly used oral non-steroidal anti-inflammatory medication phenylbutazone (Bute).
Osteoarthritis has a major impact on pain and athleticism of horses, and many medications are used to combat it. At the 2007 American Association of Equine Practitioners Convention, held Dec. 1-5 in Orlando, Fla., an in vitro study comparing
Osteoarthritis is the most common human joint disorder in the world, and in the equine industry it’s the most economically important disease. It’s the primary cause of decreased athletic function and wastage in racehorses.
Does Surpass really work to improve joint health, or is it just another way of delivering a painkiller? CSU researchers set out to answer that question.
Canadian researchers recently compared the pharmacologic properties of two different forms of glucosamine–hydrochloride and sulphate. They measured significantly higher levels of glucosamine in synovial fluid samples from horses receiving the oral
For the study, 39 horses in Missouri and Florida (on a broodmare farm, a Thoroughbred retirement center, and in two university equestrian programs) were selected for naturally occurring osteoarthritis that caused Grade 2-4 lameness on a scale of 0-4.
Italian researchers have devised a novel technique for evaluating osteoarthritis in performance horses via measurement of metabolic products in synovial fluid. They do this by using a specialized imaging technique for liquids known as proto
Stay on top of the most recent Horse Health news with
